Legato Capital Management LLC Biodesix Inc Transaction History

Legato Capital Management LLC

  • $718 Million
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 12, 2023
BUY
$1.04 - $1.74 $347,682 - $581,699
334,310 New
334,310 $551,000
Q2 2023

Aug 17, 2023
BUY
$1.12 - $1.88 $166,773 - $279,941
148,905 Added 72.62%
353,957 $435,000
Q1 2023

May 25, 2023
BUY
$1.52 - $2.5 $263,105 - $432,740
173,096 Added 541.67%
205,052 $381,000
Q4 2022

Feb 01, 2023
BUY
$0.98 - $2.3 $31,316 - $73,498
31,956 New
31,956 $73,000

Others Institutions Holding BDSX

# of Institutions
59
Shares Held
62.2M
Call Options Held
2.6K
Put Options Held
10.1K
View Full List

About BIODESIX INC

BDSX Quotes by TradingView
  • Ticker BDSX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 39,982,000
  • Market Cap $40.8M
  • Description
  • Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the appropriate treatment pat...
More about BDSX
Track This Portfolio

Track Legato Capital Management LLC Portfolio

Follow Legato Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legato Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Legato Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email